Brief: FDA In Safety Communication Says Do Not Use BioZorb Marker Implantable Radiographic Marker Devices
Oct 25 (Reuters) - FDA:
* FDA IN SAFETY COMMUNICATION SAYS DO NOT USE BIOZORB MARKER
IMPLANTABLE RADIOGRAPHIC MARKER DEVICES
* FDA: HOLOGIC RECALL DUE TO REPORTS OF SERIOUS ADVERSE
EVENTS
OCCURRING IN PATIENTS WHO HAD BIOZORB MARKER DEVICES IMPLANTED
IN BREAST TISSUE
Further company coverage: HOLX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Hologic
See all newsBrief: Blackstone And Tpg Complete Acquisition Of Hologic
Casey's General Stores edges higher ahead of replacing Hologic in S&P 500
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
Brief: S&P Dow Jones Indices Says Casey's General Stores Inc. Will Replace Hologic Inc. In The S&P 500 Effective Prior To The Market Open On April 9